Market Dynamics and Expansion of the Congenital Adrenal Hyperplasia Treatment Market
The intersection of molecular diagnostics and rare disease therapeutics is giving rise to a new era of targeted medical treatments. For decades, managing congenital adrenal hypoplasia meant dealing with the structural consequences of enzyme deficiencies through broad steroid therapies. However, recent advances in genetic engineering and structural biology are shifting the focus toward fixing or...
0 Σχόλια 0 Μοιράστηκε 254 Views 0 Προεπισκόπηση